High

Step 1: The sentiment in the management's discussion is cautious and somewhat pessimistic due to the impact of the COVID-19 pandemic on their business. While some recovery was observed in the third quarter of 2020, uncertainties remain, as stated, "The consequences of COVID-19 continue to be extremely fluid," and "COVID-19 continues to bring near-term uncertainty."

Step 2: The company experienced a significant decline in net sales in the first and second quarters of 2020 due to the deferral of elective surgical procedures, which resulted in a net loss of $472.6 million in the nine-month period ended September 30, 2020. Additionally, they recognized $645.0 million of goodwill and intangible asset impairment charges in the same period, and they mentioned ongoing uncertainties such as the potential resurgence of the virus and economic downturn impacting their near-term performance.

Step 3: Despite some recovery in the third quarter of 2020 with a 2.0 percent net sales growth compared to the same prior year period, the company highlighted that the recovery curve flattened towards the end of the quarter, and uncertainties remain. They also mentioned that the recovery varied significantly by region, with some regions experiencing declines in net sales.

Based on the cautious sentiment, the significant net sales decline in the first and second quarters, the substantial net loss and impairment charges in the nine-month period, and the uncertainties highlighted by the company, it seems that the company is at a high risk of bankruptcy in the future. The adverse effect of the COVID-19 pandemic on their liquidity and the ongoing uncertainties about their performance further support this assessment.